Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H Martin

Showing results (51-60 of 184) with videos related to

Pageof 19
Sort By:
Internal Medicine Journal|August 8, 2017
Predicting drug interactions in addiction treatmentCatherine J Lucas, Joanne Patel, Jennifer H Martin
Current Diabetes Reviews|August 20, 2009
Role of statins in diabetes complicationsJennifer H Martin, Salvatore Mangiafico, Darren J Kelly
Pharmacoepidemiology and Drug Safety|July 13, 2010
Marked increase in proton pump inhibitors use in AustraliaSamantha Hollingworth, Emma L Duncan, Jennifer H Martin
European Journal of Pain (London, England)|October 10, 2017
Comment on a paper by Dupoiron et al. "A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone- naloxone (up to 160/80 mg daily) versus oxycodone PR"Joanne Patel, Jennifer H Martin, Catherine J Lucas
Heliyon|June 16, 2023
COVID infection in 4 steps: Thermodynamic considerations reveal how viral mucosal diffusion, target receptor affinity and furin cleavage act in concert to drive the nature and degree of infection in human COVID-19 diseaseMarko Popovic, Jennifer H Martin, Richard J Head
Clinical Pharmacokinetics|April 18, 2016
How 'Optimal' are Optimal Sampling Times for Tyrosine Kinase Inhibitors in Cancer? Practical ConsiderationsMichael B Ward, Stephanie E Reuter, Jennifer H Martin
British Journal of Clinical Pharmacology|December 21, 2019
Vancomycin: Audit of American guideline-based intermittent dose administration with focus on overweight patientsMari Koyanagi, Rebecca Anning, Mark Loewenthal, et al.
International Journal of General Medicine|June 11, 2016
Diagnostic errors in older patients: a systematic review of incidence and potential causes in seven prevalent diseasesThomas R Skinner, Ian A Scott, Jennifer H Martin
British Journal of Clinical Pharmacology|January 18, 2014
A new frontier in haematology - combining pharmacokinetic with pharmacodynamic factors to improve choice and dose of drugDavid Rey Arpon, Maher K Gandhi, Jennifer H Martin
Pharmacology Research & Perspectives|March 2, 2024
Phenotype versus genotype to optimize cancer dosing in the clinical setting-focus on 5-fluorouracil and tyrosine kinase inhibitorsJennifer H Martin, Peter Galettis, Alex Flynn, et al.
Pageof 19

Showing results (51-60 of 184) with videos related to

Sort By:
Pageof 19
Internal Medicine Journal|August 8, 2017
Predicting drug interactions in addiction treatmentCatherine J Lucas, Joanne Patel, Jennifer H Martin
Current Diabetes Reviews|August 20, 2009
Role of statins in diabetes complicationsJennifer H Martin, Salvatore Mangiafico, Darren J Kelly
Pharmacoepidemiology and Drug Safety|July 13, 2010
Marked increase in proton pump inhibitors use in AustraliaSamantha Hollingworth, Emma L Duncan, Jennifer H Martin
European Journal of Pain (London, England)|October 10, 2017
Comment on a paper by Dupoiron et al. "A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone- naloxone (up to 160/80 mg daily) versus oxycodone PR"Joanne Patel, Jennifer H Martin, Catherine J Lucas
Heliyon|June 16, 2023
COVID infection in 4 steps: Thermodynamic considerations reveal how viral mucosal diffusion, target receptor affinity and furin cleavage act in concert to drive the nature and degree of infection in human COVID-19 diseaseMarko Popovic, Jennifer H Martin, Richard J Head
Clinical Pharmacokinetics|April 18, 2016
How 'Optimal' are Optimal Sampling Times for Tyrosine Kinase Inhibitors in Cancer? Practical ConsiderationsMichael B Ward, Stephanie E Reuter, Jennifer H Martin
British Journal of Clinical Pharmacology|December 21, 2019
Vancomycin: Audit of American guideline-based intermittent dose administration with focus on overweight patientsMari Koyanagi, Rebecca Anning, Mark Loewenthal, et al.
International Journal of General Medicine|June 11, 2016
Diagnostic errors in older patients: a systematic review of incidence and potential causes in seven prevalent diseasesThomas R Skinner, Ian A Scott, Jennifer H Martin
British Journal of Clinical Pharmacology|January 18, 2014
A new frontier in haematology - combining pharmacokinetic with pharmacodynamic factors to improve choice and dose of drugDavid Rey Arpon, Maher K Gandhi, Jennifer H Martin
Pharmacology Research & Perspectives|March 2, 2024
Phenotype versus genotype to optimize cancer dosing in the clinical setting-focus on 5-fluorouracil and tyrosine kinase inhibitorsJennifer H Martin, Peter Galettis, Alex Flynn, et al.
Pageof 19